Assess the impact of dietary omega 3 free fatty acids breast cancer patients.
Prospective, single arm, short term study with correlative biomarker endpoints. Two hundred (200) newly diagnosed breast cancer patients will be recruited to participate in a short term (30 day) Phase 0 biomarker evaluation study prior to surgical resection. Patients will be receive fish Oil (Omega-3 FFAs, 2700 mg by mouth twice daily).
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
21
Omega-3 Free Fatty Acid will be given as a fish oil in a capsule.
CTRC at University of Texas Health Science Center San Antonio
San Antonio, Texas, United States
Change in serum colony stimulating factor at surgery
Time frame: 30 days
Change in circulating levels of pro-inflammatory cytokines.
Time frame: 30 days
Change in circulating levels of eicosanoids.
Time frame: 30 days
Change in circulating levels of metabolics.
Time frame: 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.